Potential therapeutics for effort-related motivational dysfunction: assessing novel atypical dopamine transport inhibitors
- PMID: 38429498
- PMCID: PMC11224370
- DOI: 10.1038/s41386-024-01826-1
Potential therapeutics for effort-related motivational dysfunction: assessing novel atypical dopamine transport inhibitors
Abstract
People with depression and other neuropsychiatric disorders can experience motivational dysfunctions such as fatigue and anergia, which involve reduced exertion of effort in goal-directed activity. To model effort-related motivational dysfunction, effort-based choice tasks can be used, in which rats can select between obtaining a preferred reinforcer by high exertion of effort vs. a low effort/less preferred option. Preclinical data indicate that dopamine transport (DAT) inhibitors can reverse pharmacologically-induced low-effort biases and increase selection of high-effort options in effort-based choice tasks. Although classical DAT blockers like cocaine can produce undesirable effects such as liability for misuse and psychotic reactions, not all DAT inhibitors have the same neurochemical profile. The current study characterized the effort-related effects of novel DAT inhibitors that are modafinil analogs and have a range of binding profiles and neurochemical actions (JJC8-088, JJC8-089, RDS3-094, and JJC8-091) by using two different effort-related choice behavior tasks in male Sprague-Dawley rats. JJC8-088, JJC8-089, and RDS3-094 significantly reversed the low-effort bias induced by the VMAT-2 inhibitor tetrabenazine, increasing selection of high-effort fixed ratio 5 lever pressing vs. chow intake. In addition, JJC8-089 reversed the effects of tetrabenazine in female rats. JJC8-088 and JJC8-089 also increased selection of high-effort progressive ratio responding in a choice task. However, JJC8-091 failed to produce these outcomes, potentially due to its unique pharmacological profile (i.e., binding to an occluded conformation of DAT). Assessment of a broad range of DAT inhibitors with different neurochemical characteristics may lead to the identification of compounds that are useful for treating motivational dysfunction in humans.
© 2024. The Author(s), under exclusive licence to American College of Neuropsychopharmacology.
Conflict of interest statement
The authors declare no competing interests.
Figures





Similar articles
-
Contrasting the reinforcing effects of the novel dopamine transport inhibitors JJC8-088 and JJC8-091 in monkeys: Potential translation to medication assisted treatment.J Pharmacol Exp Ther. 2025 Jan;392(1):100033. doi: 10.1124/jpet.124.002356. Epub 2024 Nov 22. J Pharmacol Exp Ther. 2025. PMID: 39892998
-
Behavioral and dopamine transporter binding properties of the modafinil analog (S, S)-CE-158: reversal of the motivational effects of tetrabenazine and enhancement of progressive ratio responding.Psychopharmacology (Berl). 2020 Nov;237(11):3459-3470. doi: 10.1007/s00213-020-05625-6. Epub 2020 Aug 7. Psychopharmacology (Berl). 2020. PMID: 32770257 Free PMC article.
-
The novel atypical dopamine transport inhibitor CT-005404 has pro-motivational effects in neurochemical and inflammatory models of effort-based dysfunctions related to psychopathology.Neuropharmacology. 2021 Feb 1;183:108325. doi: 10.1016/j.neuropharm.2020.108325. Epub 2020 Sep 19. Neuropharmacology. 2021. PMID: 32956676
-
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.Cochrane Database Syst Rev. 2008 Jul 16;(3):CD001230. doi: 10.1002/14651858.CD001230.pub2. Cochrane Database Syst Rev. 2008. PMID: 18646068
-
Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorder (ASD).Cochrane Database Syst Rev. 2023 Oct 9;10(10):CD011769. doi: 10.1002/14651858.CD011769.pub2. Cochrane Database Syst Rev. 2023. PMID: 37811711 Free PMC article.
Cited by
-
Pharmacological characterization of sex differences in the effects of dopaminergic drugs on effort-based decision making in rats.Psychopharmacology (Berl). 2024 Oct;241(10):2033-2044. doi: 10.1007/s00213-024-06615-8. Epub 2024 Jun 6. Psychopharmacology (Berl). 2024. PMID: 38842701
References
-
- Salamone JD, Correa M. The neurobiology of activational aspects of motivation: exertion of effort, effort-based decision making, and the role of dopamine. Annu Rev Psychol. 2024;75:1–32. - PubMed
-
- Salamone JD, Ecevitoglu A, Carratala-Ros C, Presby RE, Edelstein GA, Fleeher R, et al. Complexities and paradoxes in understanding the role of dopamine in incentive motivation and instrumental action: exertion of effort vs. anhedonia. Brain Res Bull. 2022;182:57–66. - PubMed
-
- Treadway MT, Salamone JD. Vigor, Effort-related aspects of motivation and anhedonia. Curr Top Behav Neurosci. 2022;58:325–54. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources